There are only two FDA-approved semaglutide drugs available by prescription
The feds are cracking down on unapproved sales of weight lossdrugs claiming to contain Ozempic'sactive ingredient, semaglutide. Ozempen.com is the latest to get caught in the crosshairs.
Ozempen.com, which advertises the "same active ingredient as Ozempic, Rybelsus, and Wegovy, now more budget-friendly," is selling unapproved, misbranded injectable drugs that carry health risks,the U.S. Food and Drug Administration said Tuesday.
There are two FDA-approved semaglutide drugs available by prescription, Ozempic and Wegovy, but none for the4mg Semaglutide Pen and 8mg Semaglutide Pen sold on Ozempen.com, the FDA said.
This is the sixth warning letter the FDA has sent regardingOzempic or semaglutide drugs since 2023, including to Dashpct.com, Gorillahealing.com and Semaspace.com.
The warnings come at a time whenOzempic-related scams are on the rise. People are getting targeted through email phishing scams and scammers impersonating doctors online. Phishing attempts about weight loss drugs were up 183% in the first quarter of 2024 compared with the fourth quarter of 2023, according to cybersecurity company McAfee.
ConsumerAffairs has reached out to the FDA for comment about their priorities on weight-loss drugs and we will update this article if they get back.
Photo Credit: Consumer Affairs News Department Images
Posted: 2024-07-03 14:43:13